Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01823991 | COGNUTRIN in Breast Cancer Survivors | completed | Early Phase 1 | 36 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT00510367 | Primary Breast Cancer Occurring Concomitant With Pregnancy | completed | Early Phase 1 | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT02802098 |
| Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer |
| completed |
| Early Phase 1 |
| 25 |
| Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER |
| 1 |
| Jun 19, 2020 |
| clinicaltrials |
| NCT03592121 | Study to Investigate the Effect of AB-101 in Breast Cancer Survivors | completed | Early Phase 1 | 3 | Applied Biology, Inc.INDUSTRY | 1 | Mar 12, 2020 | clinicaltrials |
| NCT00331630 | Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT04289532 | Integrin α6-targeted SPECT Imaging of Breast Cancer | completed | Early Phase 1 | 9 | Peking UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT01380353 | Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT04145323 | Novel Application of Indocyanine Green as a Biomarker to Identify Tissue Necrosis in Mastectomy Patients | completed | Early Phase 1 | 10 | University of Wisconsin, MadisonOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT01894451 | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy | completed | Early Phase 1 | 2 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01263613 | Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer | completed | Early Phase 1 | 6 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT01753908 | Broccoli Sprout Extract in Treating Patients With Breast Cancer | completed | Early Phase 1 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Oct 31, 2019 | clinicaltrials |
| NCT02316795 | Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | completed | Early Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT01730729 | Cabergoline in Metastatic Breast Cancer | completed | Early Phase 1 | 20 | Northwestern UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT02806817 | ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism | completed | Early Phase 1 | 40 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT01660529 | Multi-peptide Vaccine With Basilixumab for Breast Cancer | completed | Early Phase 1 | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT00908791 | Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | completed | Early Phase 1 | 24 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 1, 2019 | clinicaltrials |
| NCT00640861 | Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer | completed | Early Phase 1 | 45 | Mayo ClinicOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT02802748 | Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA) | completed | Early Phase 1 | 60 | SOLTI Breast Cancer Research GroupOTHER | 1 | Sep 20, 2018 | clinicaltrials |
| NCT00986609 | MUC1 Vaccine for Triple-negative Breast Cancer | completed | Early Phase 1 | 29 | Joseph Baar, MD, PhDOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03546478 | 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization | completed | Early Phase 1 | 32 | Peking Union Medical College HospitalOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01793948 | Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer | completed | Early Phase 1 | 24 | Anna Maria StornioloOTHER | 1 | Mar 30, 2018 | clinicaltrials |
| NCT02077998 | Oxaliplatin in Treating Patients With Metastatic Breast Cancer | completed | Early Phase 1 | 1 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02463383 | Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women(EPPNASE) | completed | Early Phase 1 | 25 | Professor Lars Ove DragstedOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT01864083 | FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients | completed | Early Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT01468649 | Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer | completed | Early Phase 1 | 50 | Beth Israel Deaconess Medical CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT01313039 | Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer | completed | Early Phase 1 | 4 | University of MiamiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01659645 | Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast | completed | Early Phase 1 | 12 | Emory UniversityOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT00534755 | Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present | completed | Early Phase 1 | 10,000 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02679586 | Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy | completed | Early Phase 1 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 11, 2016 | clinicaltrials |
| NCT00527293 | Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer | completed | Early Phase 1 | 29 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 25, 2015 | clinicaltrials |
| NCT00826488 | A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses | completed | Early Phase 1 | 136 | Washington University School of MedicineOTHER | 1 | Jun 2, 2015 | clinicaltrials |
| NCT01805089 | Melatonin Versus Placebo in Breast Cancer | completed | Early Phase 1 | 95 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | completed | Early Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT01513356 | Pharmacodynamic Study of BKM120 in Breast Cancer | completed | Early Phase 1 | 20 | Sofia Perea, Director Clinical Trials Unit.OTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01697345 | Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | completed | Early Phase 1 | 12 | Creighton UniversityOTHER | 1 | Jan 24, 2014 | clinicaltrials |
| NCT00301041 | Radiation Therapy in Treating Women With Invasive Breast Cancer | completed | Early Phase 1 | 20 | University of California, San FranciscoOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT01684579 | Exercising Our ABC's (African- American Breast Cancer Survivors) | completed | Early Phase 1 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00991978 | VEGF Early Imaging for Breast Cancer | completed | Early Phase 1 | 23 | University Medical Center GroningenOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00572598 | Pilot Study of 18F Fluoropaclitaxel (FPAC) | completed | Early Phase 1 | 6 | Virginia Commonwealth UniversityOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00743353 | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5(K5) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Feb 2, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Jul 14, 2020source: clinicaltrials